VELOCITY-Lung

Study of Novel Treatment Combinations in Patients With Lung Cancer

Zimberelimab (ZIM)OngoingActive not recruitingPhase 2Open NCT05633667 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…